Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

Article   Mar 28, 2017 | Original Article by Adam Tozer Ph.D

 
Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

ADCs are the next generation of cancer therapies. Credit: Lonza

 
 
 
 

RELATED ARTICLES

AACR 2017: Fuelling the 2nd Revolution in Cancer Research

Article

Learn about the key themes and biggest developments from the biggest AACR ever!

READ MORE

E-Cigarettes and 21st Century Toxicology

Article

21st Century Toxicology provides a wealth of new technology that can enable faster, more accurate and more physiologically relevant eCigarette product safety assessment. And it avoids the need for animal testing.

READ MORE

Outsourced Ion Channel Testing Trends

Article

The article describes the global trends in outsourcing of ion channel testing, discussing the results of a large survey of research labs from pharma, biotech and academia.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE